ASNSD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.782000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.586400E-01
Normal-vs-Stage2
7.219400E-01
Normal-vs-Stage3
1.529390E-01
Normal-vs-Stage4
3.870000E-01
Stage1-vs-Stage2
4.633600E-01
Stage1-vs-Stage3
1.442570E-01
Stage1-vs-Stage4
4.416800E-01
Stage2-vs-Stage3
2.803200E-01
Stage2-vs-Stage4
1.223800E-01
Stage3-vs-Stage4
7.398000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.837400E-01
Normal-vs-AfricanAmerican
9.156600E-01
Normal-vs-Asian
4.701200E-01
Caucasian-vs-AfricanAmerican
8.447000E-01
Caucasian-vs-Asian
3.232000E-01
AfricanAmerican-vs-Asian
4.885800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.043600E-01
Normal-vs-Female
8.759200E-01
Male-vs-Female
3.692600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.822820E-01
Normal-vs-Age(41-60Yrs)
9.320000E-01
Normal-vs-Age(61-80Yrs)
6.824800E-01
Normal-vs-Age(81-100Yrs)
3.987400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.827750E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.293200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.941600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.688400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.211400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.196600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.964400E-01
Normal-vs-Daily Drinker
2.949400E-01
Normal-vs-Weekly Drinker
9.274600E-01
Normal-vs-Occasional Drinker
8.934800E-01
Normal-vs-Social Drinker
7.649000E-01
Non Drinker-vs-Daily Drinker
9.621200E-01
Non Drinker-vs-Weekly Drinker
1.059980E-01
Non Drinker-vs-Occasional Drinker
3.072200E-02
Non Drinker-vs-Social Drinker
2.807800E-01
Daily Drinker-vs-Weekly Drinker
1.210160E-01
Daily Drinker-vs-Occasional Drinker
4.140100E-02
Daily Drinker-vs-Social Drinker
3.009800E-01
Weekly Drinker-vs-Occasional Drinker
7.058400E-01
Weekly Drinker-vs-Social Drinker
7.054800E-01
Occasional Drinker-vs-Social Drinker
4.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.409000E-01
Normal-vs-Grade 2
5.593400E-01
Normal-vs-Grade 3
5.985600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.144600E-01
Grade 1-vs-Grade 3
6.564200E-01
Grade 1-vs-Grade 4
2.409000E-01
Grade 2-vs-Grade 3
3.593000E-01
Grade 2-vs-Grade 4
5.593400E-01
Grade 3-vs-Grade 4
5.985600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.544800E-01
Normal-vs-NonDiabetic
7.013000E-01
Diabetic-vs-NonDiabetic
4.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.680000E-01
Normal-vs-NoPancreatitis
7.414800E-01
Pancreatitis-vs-NoPancreatitis
1.828800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.547000E-01
Normal-vs-N1
7.987200E-01
N0-vs-N1
7.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.477000E-01
Normal-vs-TP53-NonMutant
9.713000E-01
TP53-Mutant-vs-TP53-NonMutant
6.478000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
